Website profiles · Technology insights · Alternatives

whiov.ac.cn

The Wuhan Institute of Virology (WIV) is a research institute of the Chinese Academy of Sciences (CAS), founded in 1956 and based in Wuhan, China. It is described as a comprehensive research institution focused on basic virology research and related technological innovation, with work spanning virology, emerging biotechnologies, and biosafety.

No paid content found
Visit website
Profile views 0 Outbound visits 0 Normal
中国科学院武汉病毒研究所 Full homepage screenshot

At a glance

Category
Security & Privacy
Language
English
Paid-content signal
No paid content foundObserved
Registered
1997
Hosting
cas.cnInferred
HTTPS certificate trusted
FailedObserved
Last updated

Website review

This review may include AI-generated content and is not individually verified. Domain, certificate and other facts come from the observed data on this page.

What is the Wuhan Institute of Virology, Chinese Academy of Sciences?

The Wuhan Institute of Virology (WIV) is a research institute of the Chinese Academy of Sciences (CAS), founded in 1956 and based in Wuhan, China. It is described as a comprehensive research institution focused on basic virology research and related technological innovation, with work spanning virology, emerging biotechnologies, and biosafety.

中国科学院武汉病毒研究所

What it does

According to the institute's own description, its research targets China's biosafety strategy, public health, and sustainable agricultural development. It relies on a CAS high-level biosafety laboratory cluster platform and carries out both basic and applied basic research.

Its website organizes activity into recognizable areas:

  • Research: research progress, results, research units, and cooperation and exchange
  • People: researchers at several career stages, plus postdoctoral positions
  • Training: graduate education, admissions information, and student profiles
  • Platforms and public information: scientific platforms, databases, journals and societies, annual reports, and information disclosure

Recent items listed on the site include work on phage therapy failure mechanisms, antiviral drug research against Japanese encephalitis virus, Ebola virus crossing the blood–testis barrier, Crimean–Congo hemorrhagic fever virus replication and nucleoside inhibitors, and invertebrate large DNA virus entry mechanisms. This range illustrates that WIV is not limited to one pathogen; it covers medically and agriculturally important viruses, plus the biosafety and laboratory-management side of the field.

Who it is for

The site serves several distinct audiences rather than the general public alone:

Audience What they will find useful
Prospective graduate students Admissions notices, recommended exemption (推免) registration, master's program catalogs and exam information
Researchers and collaborators Research progress, academic conferences, seminars, and joint research center exchanges
Job seekers Recruitment notices for overseas talent, permanent positions, and facility leadership roles
Biosafety professionals Training courses on biosafety laboratory management and experimental techniques
Science communicators and families Public science activities, such as the "first science lesson" family exploration event

A practical next step

If your interest is specific, go straight to the relevant section rather than the homepage news feed. A prospective applicant should start with the admissions notices; a researcher looking for collaboration should scan research progress and academic activities for teams working on a matching virus family; a journalist or student wanting an overview should read the institute profile and annual report. Note that much of the site's operational content is in Chinese, so plan for translation if you do not read Chinese.

What biosafety levels and high-containment laboratory facilities does the institute operate?

The site does not list specific biosafety levels or name individual high-containment laboratories. What it does establish is that high-level biosafety facilities are central to the institute's mission: the Wuhan Institute of Virology, Chinese Academy of Sciences describes itself as relying on a "cluster platform of high-grade biosafety laboratories" to carry out basic and applied research in virology, emerging biotechnology and biosafety.

What the site supports

  • The institute is a comprehensive virology research organization founded in 1956, oriented toward national biosafety needs, public health and sustainable agriculture.
  • Its research scope includes virology, emerging biotechnology and biosafety.
  • A national key laboratory for highly pathogenic viruses and biosafety appears among its academic activities, which indicates work on dangerous pathogens is part of its research environment.
  • Training and management of biosafety laboratories is an ongoing activity; the institute has run courses on biosafety laboratory management and experimental techniques.

What is not stated

  • No BSL-1, BSL-2, BSL-3 or BSL-4 designations are given.
  • No laboratory names, containment capacities, engineering features or certification details are provided.
  • No statement confirms whether any particular facility is currently operating at a given containment level.

How to use this

If you need the exact containment levels or facility specifications, the institute's public homepage is not the right source. Start with the official pages for its research platforms and national key laboratory, or contact the institute directly. For a concrete example: a researcher planning a collaboration involving a highly pathogenic virus would treat the site as evidence that high-containment capability exists, but would still need direct confirmation of the specific level, available space and approval process before shipping samples or designing experiments.

How can prospective students apply for master's or doctoral programs at the Wuhan Institute of Virology?

Prospective graduate students apply through the institute's published admissions notices, not by emailing a researcher directly. The Wuhan Institute of Virology, Chinese Academy of Sciences Wuhan Institute of Virology posts its master's admissions catalogue, exam and recommendation-exemption notices, and doctoral recruitment information on its own site, and these notices are the authoritative source for deadlines, required materials and the current application system.

Typical application routes

Route Who it fits Where it starts
Recommended exemption (推免) Undergraduates in their final year who hold a recommendation quota from their home university The institute's recommendation-exemption registration notice, then the national exemption service system
Unified national exam (统考) Graduates applying for a master's by examination The institute's master's admissions catalogue, then China's national graduate admissions platform
Doctoral application Master's holders or exceptional bachelor's holders The institute's doctoral recruitment notices and the CAS admissions system

What to prepare

  • Check the current master's admissions catalogue for the exact programme, supervisor list and exam subjects before choosing a direction.
  • Confirm eligibility, language and degree requirements in the latest notice, since these change year to year.
  • Prepare transcripts, degree certificates, recommendation letters, a research statement and any publication list the notice asks for.
  • For doctoral applicants, a research proposal aligned with an advertised supervisor's area is usually more persuasive than a general statement of interest.
  • Watch the notice and announcement sections for interview, re-examination and admission-list updates; missing a re-examination window is a common reason applications fail.

Practical next step

Start from the institute's admissions and notice pages, download the most recent catalogue, and note two or three supervisors whose work matches your background — for example, antiviral drug research or virus-host interaction. Then email a short, specific enquiry only after you have read their recent papers. If your goal is a doctoral place, also compare the national CAS admissions route with the institute's own recruitment notices, because the required forms and timelines differ.

What current faculty and research positions is the institute recruiting for?

The site shows two main recruitment tracks: a standing “诚聘海内外英才” (Open Recruitment of Talents from Home and Abroad) call, and a “海外优秀青年人才” (Overseas Outstanding Young Talents) recruitment notice. A more specific recent posting advertises the head of the Laboratory Animal Center (实验动物中心负责人). The general talent calls point to research-faculty-style appointments rather than a single named vacancy.

What the postings indicate

  • Principal investigators / research leaders: The “海内外英才” call is the institute’s broad invitation for established and emerging researchers to join its research units, which span virology, emerging biotechnology and biosafety.
  • Overseas young talents: Aimed at researchers abroad considering a return or relocation, typically for independent research positions.
  • Laboratory Animal Center head: A named scientific-management role, combining research leadership with facility oversight.
  • Student and postdoc pipeline: Separate sections cover recommended admission for 2027 graduate study (推免) and master’s admissions, which supply the research groups rather than constituting faculty posts.

How to judge fit

If you are an early-career researcher, the overseas young talent route is the more targeted entry point; if you already lead a group or programme, the general talent call is broader. For a role blending science and operations, the Laboratory Animal Center head posting is the concrete example. Note that the site presents these as notices; specific rank, start date and terms are not stated in the listing text, so treat the posting itself as the authoritative source.

Next step

Check the 招聘 (Recruitment) and 通知公告 (Notices) sections for the current text of each call, and confirm whether the role sits in a research unit or a support platform such as the Laboratory Animal Center. For institutional context, see 中国科学院武汉病毒研究所.

What are the latest research breakthroughs in antiviral drugs and virus pathogenesis from the institute?

The institute's own news feed shows two active lines of work: antiviral discovery and the mechanisms by which viruses cause disease. From the page evidence, recent items include a team studying why phage-specific antibodies cause phage therapy to fail, another team's progress on drugs against Japanese encephalitis virus, work on how Ebola virus crosses the blood–testis barrier, a breakthrough on Crimean–Congo hemorrhagic fever virus (CCHFV) replication and nucleoside inhibitors, a finding on invertebrate large DNA virus entry, identification of key sites affecting orthobunyavirus virulence, and progress on human cytomegalovirus immune evasion.

What the page actually highlights

  • Antiviral drugs and inhibitors: progress on anti–Japanese encephalitis virus drugs; CCHFV replication mechanism and nucleoside-class inhibitor discovery.
  • Virus pathogenesis and host interaction: Ebola virus crossing the blood–testis barrier; orthobunyavirus virulence determinants; human cytomegalovirus immune evasion.
  • Broader virus biology: entry mechanisms of large DNA viruses in invertebrates; phage therapy failure driven by phage-specific antibodies.
  • Research environment: the institute describes itself as a comprehensive virology research institution founded in 1956, working on virology, emerging biotechnologies and biosafety, supported by a high-level biosafety laboratory cluster.

How to use this

If you are a researcher or student tracking a specific pathogen, the institute's "科研进展" (research progress) section is the fastest route to team-level findings, and each item names the group involved — for example, the CCHFV work and the Ebola blood–testis barrier study are identifiable by team. For drug-development interest, the Japanese encephalitis and CCHFV nucleoside inhibitor items are the closest to antiviral candidates; for pathogenesis, the orthobunyavirus virulence-site and HCMV immune-evasion items are more mechanism-oriented.

A practical next step: read the dated entries in order rather than the headlines alone, because the page mixes research progress with administrative and conference news. Dates shown include 2026 and 2025 items, so check the posting date before treating anything as the newest result. For official context on the institute, see 中国科学院武汉病毒研究所.

How can external researchers collaborate with the institute or access its scientific databases and journals?

External researchers typically collaborate with the Wuhan Institute of Virology (WIV) through its research units, national key laboratory, and academic-exchange channels rather than through a single self-service portal. The site's navigation includes 合作与交流 (Cooperation and Exchange), 研究单元 (Research Units), 科研平台 (Research Platforms), 科学数据库 (Scientific Databases), and 学会与期刊 (Societies and Journals), which are the relevant entry points to explore.

Practical routes in

  • Cooperation and exchange: Start with the 合作与交流 section to understand the institute's stated collaboration scope, then identify the research group whose work matches yours.
  • Research units: Use 研究单元 to find teams by topic — the site lists work on phage therapy, Japanese encephalitis virus antivirals, Ebola virus, CCHFV, and large DNA viruses of invertebrates, among others. Contacting a specific group is usually more productive than a general inquiry.
  • Platforms and the national laboratory: The 科研平台 area and the High-Level Biosafety Laboratory cluster are the infrastructure that shapes what kinds of joint work are feasible, especially for high-containment virus research.
  • Training and conferences: WIV runs biosafety laboratory management and technical training courses and hosts academic meetings such as the 葛洪论坛 (Gehong Forum) and the AIDH symposium. These are low-commitment ways to meet staff before proposing a formal project.
  • Talent and student programmes: The 招生 (admissions) and 招聘 (recruitment) sections cover graduate study, postdoctoral and overseas talent schemes — a common path for longer-term research involvement.

Databases and journals

The footer and side navigation list 科学数据库 (Scientific Databases) and 学会与期刊 (Societies and Journals). These are the institute's own gateways; access terms for any specific database or journal are set by the host institution, so check the linked pages for whether access is open, on request, or restricted to staff. The site also provides an OA login (OA登录) for its office-automation system, which is an internal staff tool, not a public data portal.

A realistic next step

If you are an academic researcher, pick one recent paper from the 科研进展 (Research Progress) list that overlaps your work, identify the corresponding team under 研究单元, and write a short, specific proposal: the question, the data or samples you can contribute, and the biosafety level involved. If you are in industry or public health, the training courses and the cooperation section are the better first contact. For general context on China's research institute system, see Chinese Academy of Sciences.

Related questions

More questions →
中国科学院武汉病毒研究所是什么机构,主要研究和招生方向有哪些?

中国科学院武汉病毒研究所(Wuhan Institute of Virology, Chinese Academy of Sciences)成立于1956年,是专业从事病毒学基础研究及相关技术创新的综合性研究机构。它面向国家生物安全战略需求,以及人口健康和农业可持续发展,依托中国科学院高等级生物安全实验室团簇平台,重点开展病毒学、新兴生物技术及生物安全等方面的基础与应用基础研究。如果你关心的是“它做什么研究、有哪些平台、怎么读研或求职、官方信息去哪看”,下面按这几条线索展开。

机构定位与研究方向

研究所的目标定位可以概括为三条主线:

  • 国家生物安全:围绕高致病性病毒和生物安全开展研究,这是其区别于普通高校病毒学实验室的核心特征。
  • 人口健康:涉及病毒感染与致病机制、抗病毒药物等方向。
  • 农业可持续发展:涉及虫媒病毒、动物病毒等与农业和公共卫生交叉的领域。

从官网公开的科研进展看,研究覆盖面较广,例如:

  • 噬菌体特异性抗体导致噬菌体治疗失败的机制(杨航团队)
  • 抗乙型脑炎病毒药物研究(王薇团队)
  • 埃博拉病毒跨越血-睾屏障的动态机制
  • CCHFV(克里米亚-刚果出血热病毒)复制机制与核苷类抑制剂发现
  • 无脊椎动物大DNA病毒入侵机制
  • 正布尼亚病毒毒力关键位点鉴定(袁志明/夏菡团队)
  • 人巨细胞病毒免疫逃逸机制(罗敏华/杨波团队)

这些条目说明其研究既包含高致病性病毒,也包含噬菌体、虫媒病毒和医学相关病毒,方法上兼顾机制研究与药物/抑制剂发现。

科研平台与学术资源

官网导航中列出的科研相关板块包括:

  • 科研系统、管理系统、支撑系统:对应研究所的内部组织架构。
  • 研究单元:各研究组和实验室的入口。
  • 科研平台:包括高等级生物安全实验室团簇平台相关设施。
  • 实验室:如“高致病性病毒与生物安全全国重点实验室”。
  • 科学数据库、学会与期刊、大科学中心:面向学术共同体的资源入口。
  • 年报、OA登录:用于查阅年度工作和内部办公系统。

需要说明的是,官网页面本身没有公开各平台的具体使用条件、开放预约方式或收费标准,这类信息需要通过对应平台的联系渠道进一步确认。

研究生教育与人才招聘

官网设有独立的研究生教育板块,包含:

  • 教育概况
  • 招生信息
  • 培养过程
  • 学子风采

从通知公告和招生栏目可以看到具体的招生节点,例如:

  • 2027年推荐免试研究生报名系统开通
  • 2026年硕士入学考试初试相关通知
  • 2026年硕士研究生招生目录

招聘方面,官网“招聘”栏目发布过:

  • “海外优秀青年人才”招聘
  • “诚聘海内外英才”(常年有效)
  • 实验动物中心负责人招聘

也就是说,硕士、博士、推免、博士后及海外人才引进都有对应的官方入口,具体条件、时间节点和材料要求以各条通知原文为准。

如何获取官方信息

  • 官网首页:whiov.ac.cn,栏目结构为“概况简介—机构设置—人才队伍—科学研究—研究生教育—党建与科学文化—科研平台—信息公开”。
  • 通知公告:发布评奖推荐、资产报废、培训班等事务性信息。
  • 招生/招聘栏目:分别汇总研究生招生和岗位招聘信息。
  • 地址:湖北省武汉市武昌区小洪山中区44号,邮编430071。
  • 备案信息:鄂ICP备案05001977号,鄂公安备42010602002421号。

官网还提供邮箱登录入口,但页面未说明账号申请方式,校外人员如需联系,建议通过研究所公开的联系渠道或对应业务部门进行。

常见问题

它是大学还是研究所? 是中国科学院下属的研究机构,不是高校,但设有研究生教育并招收硕士、博士研究生。

主要研究什么病毒? 公开进展涉及埃博拉病毒、CCHFV、乙型脑炎病毒、正布尼亚病毒、人巨细胞病毒、噬菌体等,覆盖高致病性病毒和医学/农业相关病毒。

普通人能去参观或使用平台吗? 官网未公开面向公众的参观或平台开放政策。涉及生物安全的设施通常有严格的准入管理,具体需以官方发布的信息为准。

Website Overview

Limited stack disclosure and few obvious backend markers suggest a more restrained public footprint. That reduces easy fingerprinting clues but is not proof of overall security. An established domain and managed infrastructure suggest continuity of operations and may support dependable delivery, although neither guarantees service quality.

Domain and Registration

Registered in 1997, this domain has about 29 years of history. That suggests continuity, although ownership and purpose may have changed. The domain uses the common .cn extension, which is not an independent safety signal.

DNS and Email

The observed email authentication setup is incomplete: DMARC is missing. Nameservers are provided by sfn.cn, indicating managed DNS hosting. MX records point to the cstnet.cn email service. DNSSEC signatures were not detected, so this additional DNS authenticity protection is not confirmed. The lowest observed DNS TTL is 600 seconds.

TLS and Certificates

The certificate includes the organization field CN. The certificate uses an RSA 2048-bit public key, offering broad client compatibility. The certificate is valid for about 1825 days in total, with 138 days remaining.

HTTP and Browser Security

The response lacks these common security headers: HSTS, Permissions-Policy. No X-Powered-By header was found, reducing one common source of backend fingerprinting information. No obvious internal addresses or debug information were found in the headers. Cookie security attributes are unknown. No explicit CDN or WAF marker was found in the response headers.

Technology Stack Analysis

No obvious technology stack is exposed. This may reflect restrained information disclosure, although the underlying technologies remain unknown.

Search and Social Sharing

No homepage canonical URL was detected. If duplicate URLs exist, consolidation may be less explicit. No Open Graph metadata was detected, so social previews may depend on platform inference. The title has 12 characters, within a common display range. A meta description is present, with 140 characters. The observed directives allow indexing and link following.

Hosting and Email

DNSsfn.cn
Hostingcas.cn
Emailcstnet.cn
Approximate IP geolocation (inferred; a CDN or proxy may differ from the origin server) China flagBeijing, China Inferred 159.226.242.62

Registration details

RDAP / WHOIS

Registrar北京国科云计算技术有限公司(原北京中科三方网络技术有限公司)
Registered1997-03-02
Expires2031-07-01
Domain statusok
Nameserversns1.sfn.cn、ns2.sfn.cn
DNSSECunsigned

DNS records

DNS

TypeNameValueTTLPriority
Awhiov.cas.cn159.226.242.623600—
MXwhiov.ac.cnmx.cstnet.cn864001
NSwhiov.ac.cnns1.sfn.cn86400—
NSwhiov.ac.cnns2.sfn.cn86400—
TXTwhiov.ac.cnv=spf1 include:spf.mail.cstnet.cn -all600—
CNAMEwww.whiov.ac.cnwhiov.cas.cn600—

TLS and certificates

TLS / SSL

AssessmentCertificate issue
Supported protocolsTLSv1.2、TLSv1.3
Negotiated protocolTLSv1.3
Certificate subjectcn
IssuerCN
Valid until2027-03-02T07:10 · Remaining when checked: 138 days
Verification detailsCertificate trust: Failed · Hostname match: Failed

HTTP response headers

HTTP

HeaderValue
content-typetext/html
content-security-policyframe-ancestors *.cas.cn
x-frame-optionsSAMEORIGIN
x-content-type-optionsnosniff
referrer-policystrict-origin-when-cross-origin
set-cookieRedacted

Identified technologies

Technology stack: Unknown

Pages, Search and Sharing

Meta description中国科学院武汉病毒研究所成立于1956年,是专业从事病毒学基础研究及相关技术创新的综合性研究机构。研究所的目标定位是针对国家生物安全的战略需求和人口健康、农业可持续发展,依托中国科学院高等级生物安全实验室团簇平台,重点开展病毒学、新兴生物技术及生物安全等方面的基础和应用基础研究。
Canonical URLNot detected
LanguageEnglish (default)
Twitter CardNot detected

Unknown

No robots.txt found

No sitemaps found

User reviews (0)

  • No reviews yet.